A company before the demerger
Incorporation left a 27-day reporting period supported by Liontown. The August agreement and September approval were subsequent events.
Minerals 260 changed scale twice: first through the Liontown demerger and exploration portfolio, then through the Bullabulling gold acquisition. The key distinction is accounting, not just size—early acquisition costs dominated losses, while Bullabulling created a substantial acquired asset backed by new equity. Cash spending, reported losses and project carrying values tell different parts of that story.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
After funding and acquisition cash flows.
Bullabulling allocation—not a mineral valuation.
Separate from acquisition investing outflows.
Consolidated Group at June 2025.
FY2021 was only 27 days, before the demerger. The ERL acquisition agreement and shareholder approval followed after June, and the October 2021 IPO falls in FY2022. The opening company snapshot is therefore shown separately from the later Group.
The FY2022 loss included a large non-cash acquisition expense. FY2025 instead combined cash/equity acquisition funding with a large exploration-asset balance. Neither the earlier loss nor the later asset increase is annual operating cash generation.
Incorporation left a 27-day reporting period supported by Liontown. The August agreement and September approval were subsequent events.
The October listing raised cash; ERL was acquired through share consideration and exploration expense. The headline loss greatly exceeded annual cash use.
Aston was acquired using shares and cash, while drilling continued at Moora and Koojan. Acquisition costs remained material within exploration expense.
Aston reconnaissance and Moora drilling continued. Operating expenditure reduced cash without a new cash equity inflow.
April completion accompanied the public offer. Bullabulling dominated exploration expense; Aston was sold for cash plus a retained royalty.
The opening company had a capital receivable and a repayable-on-demand, non-interest-bearing parent loan, but no active bank account. This predates the demerger and is not a full twelve-month exploration cash-flow record.
A$
| Metric | FY2021 |
|---|---|
| Net loss | (1,124) |
| Total assets | 1,000 |
| Loan from Liontown / total liabilities | 1,124 |
| Issued share capital | 1,000 |
| Equity deficiency | (124) |
Australian dollars, not millions. Incorporation on 4 June to 30 June 2021 precedes the demerger and portfolio acquisition.
No active bank account; the company relied on parent support. The capital receivable is not cash. This opening company is not directly comparable with the later Group.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
ERL share consideration was expensed under the company’s policy. The FY2022 loss does not mean a similar amount of cash was consumed. Aston consideration and related acquisition costs again made FY2023 exploration expense larger than exploration cash paid.
The lower FY2024 loss partly reflects the absence of large acquisition charges, not simply lower ordinary overheads: corporate costs increased. FY2025 exploration accelerated after Bullabulling, while corporate costs included re-listing and compliance activity.
Share-based compensation is separate from project-acquisition consideration. It affects statutory results without an equal cash payment and must not be counted again inside supplier cash payments.
A$ million
AI-generated presentation · values from Group losses and the costs behind them; no missing values plotted as zero.
A$ million
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Net loss after tax | (88.590) | (13.106) | (7.709) | (11.520) |
| Exploration and evaluation expensed | (84.022) | (10.573) | (3.585) | (7.193) |
| Corporate and administrative expenses | (1.078) | (1.892) | (2.748) | (4.040) |
| Separate share-based payment expense | (3.030) | (1.445) | (1.965) | (1.551) |
| Interest / net finance income | 0.057 | 0.804 | 0.589 | 0.814 |
FY2022 exploration expense includes A$79.9995m ERL acquisition cost; FY2023 includes A$5.587m acquisition costs, largely Aston. These are not equivalent cash exploration outflows.
FY2022 also charged A$0.518m IPO/listing expense; FY2025 also recognised a A$0.450m tenement-disposal gain. Selected components do not alone sum to net loss.
Expenses are negative. FY2022 interest income and subsequent net finance income use the statement labels. No mineral sales are inferred.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Personnel expense magnitude | 0.580 | 0.875 | 1.340 |
| Office / overhead expense magnitude | 0.193 | 0.288 | 0.283 |
| Business-development expense magnitude | 0.006 | 0.255 | 0.582 |
| Corporate depreciation magnitude | 0.002 | 0.043 | 0.132 |
Components of corporate expenses, not additional charges. Expense-note signs are normalised to positive magnitudes.
For FY2025 the issuer explains higher corporate costs through regulatory/compliance consulting and ASX re-listing expenditure. Corporate depreciation here is narrower than whole-Group depreciation.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Cash reduced through FY2023 and FY2024 as operating uses combined with small financing outflows. FY2025 equity inflow exceeded acquisition and operating uses, leaving a materially higher cash balance.
Exploration cash payments sit in operating cash flow. Bullabulling acquisition payments and transaction costs sit in investing. Separating those lanes prevents both overstating field expenditure and understating total cash deployed.
Opening shares of 234m became approximately 2,150.7m after the public offer and vendor shares. The A$10m vendor consideration increased issued capital without adding cash.
A$ million
AI-generated presentation · values from Operating cash use and acquisition-scale funding; no missing values plotted as zero.
A$ million
AI-generated presentation · values from The enlarged Group balance sheet; no missing values plotted as zero.
A$ million
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Net operating cash flow | (5.076) | (5.835) | (5.816) | (8.495) |
| Net investing cash flow | (0.102) | (0.509) | (0.100) | (158.965) |
| Net financing cash flow | 28.649 | (0.051) | (0.057) | 210.739 |
Exploration cash payments are within operating activities. Net investing is not exploration spend.
FY2023 and FY2024 financing totals are negative, reflecting issue costs/lease payments rather than new equity receipts. FY2025 includes major acquisition financing.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash paid to suppliers and employees | (0.852) | (1.748) | (2.549) | (4.672) |
| Cash paid for exploration and evaluation | (3.688) | (4.807) | (3.900) | (4.638) |
| Cash interest received | 0.033 | 0.580 | 0.685 | 0.816 |
| Cash paid for plant and equipment | (0.100) | (0.050) | (0.088) | (0.079) |
Rows are already within the cash-flow totals. Exploration expense, exploration cash paid and closing exploration assets are different measures.
FY2022 IPO receipts were A$30m before A$1.351m issue costs. FY2025 securities receipts were A$220m before A$9.080m issue costs. Vendor consideration shares did not add cash.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The contract price, cash acquisition payment and purchase-accounting allocation measure different things. Bullabulling was an asset acquisition, not a business combination. Allocated exploration assets reflect assumed obligations and must not be equated with the contractual cash price.
The enlarged balance sheet brought obligations as well as assets. Stamp duty remained within payables; rehabilitation arose from Bullabulling. These differ from the office lease and future exploration commitments.
No impairment indicator was identified for the retained capitalised exploration balance at June 2025. That does not make its carrying amount a market valuation or commercially recoverable reserve. Ongoing field expenditure remains expensed under the stated policy.
A$ million
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash and equivalents | 23.471 | 17.076 | 11.103 | 54.382 |
| Total assets | 23.730 | 17.524 | 12.046 | 238.766 |
| Total liabilities | 0.569 | 0.912 | 1.178 | 16.947 |
| Net assets / total equity | 23.160 | 16.612 | 10.868 | 221.818 |
Consolidated Group, not parent-only accounts. The FY2025 scale change reflects financing and acquisition, not operating profit.
FY2025 liabilities include A$12.154m payables, A$0.182m employee benefits, A$0.510m leases and A$4.102m rehabilitation. Payables include A$8.568m Bullabulling stamp duty.
Cash is not all surplus capital: the company requires future exploration/development funding and reported no ready access to credit facilities.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2025 |
|---|---|
| Cash-flow payment to acquire Bullabulling | (156.444) |
| Cash-flow acquisition costs paid | (2.725) |
| Non-cash consideration shares | 10.000 |
| Purchase-accounting allocation total | 177.736 |
| Exploration assets acquired | 181.842 |
| Receivables acquired | 0.040 |
| Payables assumed — allocation deduction | (0.044) |
| Rehabilitation assumed — allocation deduction | (4.102) |
| Separate Belararox option asset | 0.150 |
| Closing exploration and evaluation assets | 181.992 |
Different measures, not one additive list. Contractual headline price: A$166.5m, comprising A$156.5m cash and A$10m shares. Cash-statement payment and costs appear at recorded amounts.
Acquired exploration assets plus receivables less assumed payables and rehabilitation equal the A$177.736m purchase-accounting allocation. Transaction costs and obligations distinguish this measure from the headline price.
Closing E&E equals A$181.842m acquired exploration assets plus A$0.150m Belararox option. The movement note reports no separate capitalised exploration expenditure; ongoing exploration remains a P&L charge.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Bullabulling accounted for most FY2025 exploration expense despite April completion. Earlier Moora, Koojan and Dingo Rocks expense declined. Aston was sold for cash and a 1.5% lithium net-smelter royalty; no future royalty receipts are assumed.
Drilling, resource-update and pre-feasibility plans are development context, not realised output. Exploration commitments were A$1.925m at June 2025 versus A$1.102m a year earlier, covering granted leases but excluding applications.
The company maintains cash because it does not yet have ready access to credit facilities. The balance sheet shows financing capacity at a date, not assurance that every future development cost is funded.
A$ million
AI-generated presentation · values from Exploration expense moved to Bullabulling; no missing values plotted as zero.
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Aston | 1.350 | 0.549 |
| Moora | 1.586 | 0.227 |
| Koojan | 0.226 | 0.001 |
| Dingo Rocks | 0.420 | 0.014 |
| Bullabulling | 0.000 | 6.402 |
| Acquisition costs expensed | 0.003 | 0.000 |
| Total exploration expense — magnitude | 3.585 | 7.193 |
Positive expense magnitudes, already included in the negative P&L exploration row. Neither cash payments nor acquired asset values.
Bullabulling expenditure follows April 2025 completion. Resources and development timetables are not current production or sales.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.